Istituto Di Ricovero E Cura A Carattere Scientifico - Istituto Tumori Giovanni Paolo Ii

Bari 70124

0 studies enrolling now · 1 studies all time

What they study most

Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma

Studies at this site

• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed